An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...
YouTube on MSN
Never get Alzheimer’s disease: The NAD+ breakthrough
A brand-new paper has just been published that claims to challenge the century-old dogma that Alzheimer’s disease is ...
A new study suggests that suppressing inflammation after surgery may prolong pain instead of relieving it. Taking anti-inflammatory medication after an operation is a common part of care. However, a n ...
Many people are familiar with histamine, a biological molecule that serves as a key driver of allergic reactions and other ...
A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...
Pharmaceutical Technology on MSN
InterAx and Alveus collaborate on small-molecule metabolic treatment
The agreement includes an upfront payment, with potential future payments linked to development, regulatory, and commercial ...
Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable ...
A longevity-linked metabolite restored key memory processes in Alzheimer’s models, highlighting aging biology as a promising therapeutic target. Singapore ranks among the countries with the longest ...
Activation of CRF3 reshapes root architecture, helping plants maintain growth and survive in cold soils. “Cold stress doesn’t ...
InterAx Biotech Ltd ("InterAx") and Alveus Therapeutics Inc. ("Alveus") today announced a strategic research collaboration and licensing agreement to develop a differentiated small molecule candidate ...
New Phase 2a data show the oral IPF therapy GRI-0621 modulates immune cell activity in adults with idiopathic pulmonary ...
The grant will help advance treatments for the life-threatening lung condition acute respiratory distress syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results